What Is Computer System Validation in the Pharmaceutical Industry

August 10, 2026

Computer system validation (CSV) provides documented evidence that a computerized system is fit for its intended use and performs consistently in a regulated process. In pharmaceutical operations, that assurance supports product quality, patient safety, data integrity, and compliance with applicable requirements.

CSV starts with intended use: what the system is expected to do, which regulated processes and records it supports, and what could go wrong. Validation then uses documented requirements, risk assessment, configuration controls, testing, and supporting records to demonstrate that the system performs as intended and that critical data remains accurate, complete, and reliable.

Computerized systems can support laboratory testing, manufacturing, environmental monitoring, warehousing, quality processes, and other GxP activities. The appropriate level of validation depends on the system's intended use, complexity, configuration, and potential impact on product quality, patient safety, and data integrity.

For U.S. drug manufacturers, 21 CFR 211.68 establishes controls for automatic, mechanical, and electronic equipment, including computer systems. When electronic records subject to FDA requirements are maintained electronically, 21 CFR Part 11 may also apply. For organizations operating under EU GMP, Annex 11 addresses computerized systems used in GMP-regulated activities. Together, these frameworks reinforce a lifecycle and risk-based approach to system control, validation, and data integrity.

Below, we explain how a risk-based CSV lifecycle works, which pharmaceutical systems may require validation, and how organizations maintain a validated state after initial release.

Computer System Validation and GAMP 5: A Risk-Based Lifecycle Approach

ISPE's GAMP 5 is widely used as industry guidance for applying a scalable, risk-based approach to GxP computerized systems. It is not a regulation or a mandatory five-step validation model; it helps organizations tailor lifecycle activities and documentation to intended use and risk.

A practical CSV lifecycle commonly includes the following activities:

Plan and assess risk: Define system scope, intended use, GxP impact, responsibilities, supplier considerations, and a validation strategy proportionate to risk.

Define requirements: Document user and regulatory requirements, including critical functions, data requirements, security, audit trails, interfaces, and records where applicable.

Configure and control the system: Establish the approved configuration and document custom code or configured functions to the extent appropriate for the system and its risk.

  • Verify and test: Use risk-based testing to demonstrate that critical requirements and controls work as intended, including interfaces, calculations, permissions, data handling, and relevant failure scenarios.
  • Release and report: Resolve deviations, confirm required documentation and training are complete, summarize the evidence, and formally approve the system for its intended use.
  • Maintain the validated state: Control changes, incidents, access, backups, periodic reviews, and retirement activities throughout the system lifecycle.

Qualifications such as installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) may be used where appropriate, particularly for equipment and configured systems. The specific deliverables should reflect the system, its intended use, and documented risk rather than a one-size-fits-all checklist.

Which Pharmaceutical Computer Systems May Require Validation?

Not every computer used by a pharmaceutical company requires the same level of validation. The key question is whether the computerized system supports a GxP process or regulated record and, if so, what risks its failure could create.

Common systems that may fall within a CSV program include:

  • Laboratory informatics systems: Laboratory information management systems (LIMS), chromatography data systems (CDS), electronic laboratory notebooks (ELN), and similar platforms may create, process, review, or retain GxP data.
  • Laboratory instrument software and data acquisition systems: Software connected to balances, spectrometers, particle counters, incubators, and other instruments may require validation when it performs calculations, controls workflows, or creates and retains regulated data.
  • Manufacturing, facility, and quality systems: Manufacturing execution systems (MES), PLC/SCADA applications, environmental or building monitoring systems, electronic quality management systems (eQMS), and other platforms may require validation when they control or document GxP-critical activities. The scope should be based on intended use and risk.

Best Practices for Maintaining a Validated State

Validation does not end at go-live. Updates, new interfaces, security changes, vendor releases, and changing business processes can introduce new risks. Maintaining the validated state requires ongoing controls such as:

  • Change and configuration control: Assess proposed changes for GxP impact, determine whether regression testing or revalidation is needed, document implementation, and obtain appropriate approval before release.
  • Security, data integrity, and operational controls: Maintain appropriate user access, audit trails where required, backup and recovery processes, incident management, and training for personnel who operate or administer the system.
  • Periodic review and retirement: Periodically evaluate system performance, changes, deviations, access, and continued fitness for intended use. At retirement, preserve required records and data in a form that remains accessible and reliable for the applicable retention period.

How TSS Can Support Computer System Validation

A defensible CSV program connects intended use, risk, testing, documentation, and lifecycle controls. The objective is not simply to produce validation paperwork; it is to maintain confidence that systems supporting regulated activities remain fit for use and that critical data can be trusted.

Technical Safety Services supports pharmaceutical and biotechnology organizations with testing, qualification, calibration, and validation services for regulated facilities, equipment, utilities, and computerized systems. Our approach is built around clear requirements, documented evidence, and the risks that matter to the intended use.

Whether you need support with commissioning and qualification, laboratory equipment calibration, GMP documentation, or computer system validation, TSS can help define an appropriate scope and execute the work with traceable, reviewable documentation.

A risk-based approach can focus validation effort where system failure would have the greatest impact while avoiding unnecessary testing and documentation for low-risk functions.

To discuss your validation needs, contact Technical Safety Services.

Return to Blog